These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 16050919)

  • 41. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
    Katagiri H; Takita Y; Tohen M; Higuchi T; Kanba S; Takahashi M
    Curr Med Res Opin; 2012 May; 28(5):701-13. PubMed ID: 22356118
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treating bipolar disorder. Evidence-based guidelines for family medicine.
    McIntyre RS; Mancini DA; Lin P; Jordan J
    Can Fam Physician; 2004 Mar; 50():388-94. PubMed ID: 15318676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of manic phases of bipolar disorder: critical synthesis of international guidelines].
    Geoffroy PA; Bellivier F; Henry C
    Encephale; 2014 Sep; 40(4):330-7. PubMed ID: 24513018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lithium for maintenance treatment of mood disorders.
    Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
    Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid titration of mood stabilizers predicts remission from mixed or pure mania in bipolar patients.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1998 Apr; 59(4):151-8. PubMed ID: 9590664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.
    Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ
    Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder.
    Bowden CL
    J Clin Psychiatry; 2005; 66 Suppl 3():12-9. PubMed ID: 15762830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials.
    Suppes T; Vieta E; Gustafsson U; Ekholm B
    Depress Anxiety; 2013 Nov; 30(11):1089-98. PubMed ID: 23761037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term pharmacological treatment of bipolar disorders.
    Rybakowski J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():71-93. PubMed ID: 17262006
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of mixed bipolar states.
    Fountoulakis KN; Kontis D; Gonda X; Siamouli M; Yatham LN
    Int J Neuropsychopharmacol; 2012 Aug; 15(7):1015-26. PubMed ID: 22217434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bipolar disorder therapeutics: maintenance treatment.
    Sachs GS; Thase ME
    Biol Psychiatry; 2000 Sep; 48(6):573-81. PubMed ID: 11018228
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lamotrigine (Lamictal IR) for the treatment of bipolar disorder.
    Bowden CL; Singh V
    Expert Opin Pharmacother; 2012 Dec; 13(17):2565-71. PubMed ID: 23140205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: post hoc analyses of 47-week data.
    Suppes T; Brown E; Schuh LM; Baker RW; Tohen M
    J Affect Disord; 2005 Dec; 89(1-3):69-77. PubMed ID: 16253344
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic influences on response to mood stabilizers in bipolar disorder: current status of knowledge.
    Rybakowski JK
    CNS Drugs; 2013 Mar; 27(3):165-73. PubMed ID: 23378337
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Olanzapine: a second generation antipsychotic drug and an "atypical" mood stabilizer?].
    Bánki CM
    Psychiatr Hung; 2007; 22(4):311-20. PubMed ID: 18167425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of depression in bipolar disorder: new directions for research.
    Zornberg GL; Pope HG
    J Clin Psychopharmacol; 1993 Dec; 13(6):397-408. PubMed ID: 8120153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polarity index of pharmacological agents used for maintenance treatment of bipolar disorder.
    Popovic D; Reinares M; Goikolea JM; Bonnin CM; Gonzalez-Pinto A; Vieta E
    Eur Neuropsychopharmacol; 2012 May; 22(5):339-46. PubMed ID: 22000157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.